Home
NVO
NVO News

Latest Novo Nordisk A/S (NVO) News on October 8, 2025

Novo Nordisk (NYSE:NVO): Is the Market Overlooking Its True Value?

Simply Wall St.

15 hours ago

Novo Nordisk (NYSE:NVO): Is the Market Overlooking Its True Value?

MT Newswires

15 hours ago

Sector Update: Health Care Stocks Decline Pre-Bell Tuesday

MT Newswires

17 hours ago

Novo Nordisk Loses Appeal in US Court Over Medicare Drug Price Negotiation Program

Novo Nordisk cuts hit production line jobs at key US plant, posts show

Reuters Videos

18 hours ago

Novo Nordisk cuts hit production line jobs at key US plant, posts show

MT Newswires

19 hours ago

Market Chatter: Novo Nordisk Cuts Over 9,000 Jobs Globally, Including US North Carolina Facility

What Makes Novo Nordisk A/S (NVO) a Promising and Profitable Investment in The Long Term?

Insider Monkey

2 days ago

What Makes Novo Nordisk A/S (NVO) a Promising and Profitable Investment in The Long Term?

Zacks Value Trader Highlights: Pfizer, Merck, AbbVie, Eli Lilly and Novo Nordisk

Zacks

2 days ago

Zacks Value Trader Highlights: Pfizer, Merck, AbbVie, Eli Lilly and Novo Nordisk

Skye shares crash as obesity drug falls short in key study

BioPharma Dive

2 days ago

Skye shares crash as obesity drug falls short in key study

Will Caremark’s New Wegovy Copay Program Redefine CVS Health’s (CVS) Approach to Cost and Access?

Simply Wall St.

4 days ago

Will Caremark’s New Wegovy Copay Program Redefine CVS Health’s (CVS) Approach to Cost and Access?

Novo Nordisk Is Ready for Another Round of the Weight-Loss-Drug Wars

Barrons.com

4 days ago

Novo Nordisk Is Ready for Another Round of the Weight-Loss-Drug Wars

Looking to Launch Wegovy Pill in 2026: David Moore

Bloomberg

4 days ago

Looking to Launch Wegovy Pill in 2026: David Moore

Novo Nordisk (NVO) Outpaces Stock Market Gains: What You Should Know

Zacks

4 days ago

Novo Nordisk (NVO) Outpaces Stock Market Gains: What You Should Know

5 Large Cap Drug Stocks: Values or Traps?

Zacks

4 days ago

5 Large Cap Drug Stocks: Values or Traps?

MT Newswires

4 days ago

Sector Update: Health Care Stocks Gain Late Afternoon

MT Newswires

4 days ago

Sector Update: Health Care

MT Newswires

4 days ago

Market Chatter: Novo Nordisk Plans Online Launch for New Weight-Loss Pill

Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

5 days ago

Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It

Corvus Pharmaceuticals Appoints David Moore to Board of Directors

GlobeNewswire

5 days ago

Corvus Pharmaceuticals Appoints David Moore to Board of Directors

Buy Novo Nordisk Stock as Health Names Return to Favor, Analyst Says

Barrons.com

5 days ago

Buy Novo Nordisk Stock as Health Names Return to Favor, Analyst Says

Can Novo Nordisk's Restructuring Program Drive its Return to Growth?

Zacks

6 days ago

Can Novo Nordisk's Restructuring Program Drive its Return to Growth?

Novo Nordisk (CPSE:NOVO B): Exploring Shareholder Value After Recent Period of Steady Performance

Simply Wall St.

6 days ago

Novo Nordisk (CPSE:NOVO B): Exploring Shareholder Value After Recent Period of Steady Performance

MT Newswires

6 days ago

European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading

LEXX: Biodistribution Study Results

Zacks Small Cap Research

6 days ago

LEXX: Biodistribution Study Results

MT Newswires

6 days ago

HSBC Upgrades Novo Nordisk to Buy From Hold, Lifts Price Target to $70 From $55

MT Newswires

6 days ago

Novo Nordisk Controlling Shareholder Participates in Quantum Fund Launch

Morgan Stanley Downgrades Novo Nordisk A/S (NVO) from Equal-Weight to Underweight

Insider Monkey

6 days ago

Morgan Stanley Downgrades Novo Nordisk A/S (NVO) from Equal-Weight to Underweight

MT Newswires

6 days ago

Sector Update: Health Care Stocks Rise Late Afternoon

MT Newswires

6 days ago

Sector Update: Health Care

MT Newswires

6 days ago

Market Chatter: CVS Health Introduces $200 Copay to Broaden Access to Novo Nordisk's Wegovy

MT Newswires

6 days ago

Top Midday Gainers

Why Shares in Novo Nordisk Bumped Higher Today

Motley Fool

6 days ago

Why Shares in Novo Nordisk Bumped Higher Today

MT Newswires

8 days ago

Sector Update: Health Care Stocks Flat to Lower Pre-Bell Tuesday

MT Newswires

8 days ago

Sector Update: Health Care

MT Newswires

8 days ago

Novo Nordisk's Ozempic Available Through LifeMD Platform at $499 a Month

Novo Nordisk Stock Falls After Morgan Stanley Issues Harsh Downgrade

GuruFocus.com

8 days ago

Novo Nordisk Stock Falls After Morgan Stanley Issues Harsh Downgrade

LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk

GlobeNewswire

8 days ago

LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk

Top Stocks today: Tilray, Alibaba gain; Novo Nordisk slips

TheStreet

8 days ago

Top Stocks today: Tilray, Alibaba gain; Novo Nordisk slips

Why Novo Nordisk Stock Slumped on Monday

Motley Fool

8 days ago

Why Novo Nordisk Stock Slumped on Monday

Spotify initiated with Buy, Toyota August sales, Novo downgrade

Yahoo Finance Video

8 days ago

Spotify initiated with Buy, Toyota August sales, Novo downgrade

MT Newswires

9 days ago

Novo Nordisk Resubmits Biologics License Application to FDA for Awiqli to Treat Type 2 Diabetes

MT Newswires

9 days ago

Novo Nordisk Seeks FDA Approval for Denecimig to Treat Hemophilia A

Novo Nordisk resubmits Awiqli® to the FDA with potential to be the first once-weekly basal insulin treatment for adults with type 2 diabetes

PR Newswire

9 days ago

Novo Nordisk resubmits Awiqli® to the FDA with potential to be the first once-weekly basal insulin treatment for adults with type 2 diabetes

Novo Nordisk submits Biologics License Application (BLA) to FDA for Mim8; an investigational, prophylaxis treatment for people living with hemophilia A with or without inhibitors

PR Newswire

9 days ago

Novo Nordisk submits Biologics License Application (BLA) to FDA for Mim8; an investigational, prophylaxis treatment for people living with hemophilia A with or without inhibitors

MT Newswires

9 days ago

Morgan Stanley Downgrades Novo Nordisk to Underweight From Equal Weight, Cuts Price Target to $47 From $59

MT Newswires

9 days ago

Social Buzz: Wallstreetbets Stocks Mostly Higher Premarket Monday; Tilray Brands to Rise, Novo Nordisk to Fall

Investing.com

9 days ago

M. Stanley cuts Novo Nordisk to Underweight on ’tough path ahead’, shares slip

As obesity M&A heats up, pharmas could get ‘blinded by opportunity’

Pharma Voice

9 days ago

As obesity M&A heats up, pharmas could get ‘blinded by opportunity’

FED Fitness x Talking Tom Kick Off Global #TomSaidNoSkipDay Campaign Ahead of Prime Sales Events

GlobeNewswire

10 days ago

FED Fitness x Talking Tom Kick Off Global #TomSaidNoSkipDay Campaign Ahead of Prime Sales Events

Keanu Reeves and Alex Winter on "Waiting for Godot"

CBS News Videos

10 days ago

Keanu Reeves and Alex Winter on "Waiting for Godot"

Message from the Governor General on Police and Peace Officers' National Memorial Day

CNW Group

10 days ago

Message from the Governor General on Police and Peace Officers' National Memorial Day

Reading Eagle, Pa.

10 days ago

Business Weekly Agenda for September 28

The Biotech Stock That's Too Risky for Most Investors

Motley Fool

10 days ago

The Biotech Stock That's Too Risky for Most Investors

Is Open Text Corporation's (NASDAQ:OTEX) 11% ROE Strong Compared To Its Industry?

Simply Wall St.

10 days ago

Is Open Text Corporation's (NASDAQ:OTEX) 11% ROE Strong Compared To Its Industry?

Investing in Adient (NYSE:ADNT) five years ago would have delivered you a 25% gain

Simply Wall St.

10 days ago

Investing in Adient (NYSE:ADNT) five years ago would have delivered you a 25% gain

Are Robust Financials Driving The Recent Rally In Decibel Cannabis Company Inc.'s (CVE:DB) Stock?

Simply Wall St.

10 days ago

Are Robust Financials Driving The Recent Rally In Decibel Cannabis Company Inc.'s (CVE:DB) Stock?

Is Pfizer Stock a Buy After Its $5 Billion GLP-1 Bet?

Motley Fool

11 days ago

Is Pfizer Stock a Buy After Its $5 Billion GLP-1 Bet?

3 Magnificent Stocks Under $100 to Buy Right Now

Motley Fool

11 days ago

3 Magnificent Stocks Under $100 to Buy Right Now

Trump Unveils 100% Drug Tariff, Pharma Stocks Slide

GuruFocus.com

11 days ago

Trump Unveils 100% Drug Tariff, Pharma Stocks Slide

GLP-1 race evolves as Amgen & weight-loss pills enter the scene

Yahoo Finance Video

11 days ago

GLP-1 race evolves as Amgen & weight-loss pills enter the scene

Top Analyst Reports for NVIDIA, Berkshire Hathaway & Home Depot

Zacks

11 days ago

Top Analyst Reports for NVIDIA, Berkshire Hathaway & Home Depot

These Stocks Moved the Most Today: Eli Lilly, Electronic Arts, Intel, GlobalFoundries, Boeing, AppLovin, Costco, and More

Barrons.com

11 days ago

These Stocks Moved the Most Today: Eli Lilly, Electronic Arts, Intel, GlobalFoundries, Boeing, AppLovin, Costco, and More

Morningstar Research

11 days ago

Analyst Report: Novo Nordisk A/S

Washington Is Disrupting Healthcare. 16 Stocks From Roundtable Pros That Can Win.

Barrons.com

11 days ago

Washington Is Disrupting Healthcare. 16 Stocks From Roundtable Pros That Can Win.

European Stocks Gain as Investors Upbeat on US Spending Data

Bloomberg

12 days ago

European Stocks Gain as Investors Upbeat on US Spending Data

Trump's 100% Drug Tariffs Sparks Selloff in Global Pharma Markets

GuruFocus.com

12 days ago

Trump's 100% Drug Tariffs Sparks Selloff in Global Pharma Markets

Intel, Wayfair, Eli Lilly, Oracle: Trending tickers

Yahoo Finance Video

12 days ago

Intel, Wayfair, Eli Lilly, Oracle: Trending tickers

These Stocks Are Moving the Most Today: Eli Lilly, Wayfair, Intel, Oracle, Concentrix, Costco, and More

Barrons.com

12 days ago

These Stocks Are Moving the Most Today: Eli Lilly, Wayfair, Intel, Oracle, Concentrix, Costco, and More

Eli Lilly's GLP-1 Pill Just Beat Out Novo Nordisk's in a Test. Here's 1 Thing Investors Need to Know.

Motley Fool

12 days ago

Eli Lilly's GLP-1 Pill Just Beat Out Novo Nordisk's in a Test. Here's 1 Thing Investors Need to Know.

3 Absurdly Cheap Stocks You Can Buy for Less than $100 Right Now

Motley Fool

12 days ago

3 Absurdly Cheap Stocks You Can Buy for Less than $100 Right Now

Trump Plans New Tariff Push With 100% Rate on Patented Drugs

Bloomberg

12 days ago

Trump Plans New Tariff Push With 100% Rate on Patented Drugs

European pharma shares drop after Trump threatens more tariffs

Reuters

12 days ago

European pharma shares drop after Trump threatens more tariffs

Denmark's 'Novo Town' holds its breath as Wegovy fever fades

Reuters Videos

13 days ago

Denmark's 'Novo Town' holds its breath as Wegovy fever fades

1 Reason Novo Nordisk (NVO) Is 1 of the Best Healthcare Stocks You Can Buy Today

Motley Fool

13 days ago

1 Reason Novo Nordisk (NVO) Is 1 of the Best Healthcare Stocks You Can Buy Today

3 Reasons to Buy Novo Nordisk Stock Right Now

Motley Fool

13 days ago

3 Reasons to Buy Novo Nordisk Stock Right Now

Pfizer Is Buying Weight Loss Biotech Metsera. Here's Why Viking Therapeutics Shareholders May Be Cheering.

Motley Fool

13 days ago

Pfizer Is Buying Weight Loss Biotech Metsera. Here's Why Viking Therapeutics Shareholders May Be Cheering.

Novo Nordisk A/S (NVO) Attracts Park Avenue Securities Investment

Insider Monkey

13 days ago

Novo Nordisk A/S (NVO) Attracts Park Avenue Securities Investment

Pharmaceutical Technology

13 days ago

Podcast: How oral GLP-1RAs are set to impact the obesity market

LLY vs. NVO: Which Obesity Drug Stock Is the Better Buy Now?

Zacks

13 days ago

LLY vs. NVO: Which Obesity Drug Stock Is the Better Buy Now?

MT Newswires

14 days ago

European Equities Traded in the US as American Depositary Receipts Little Changed in Wednesday Trading

Eli Lilly and Company (LLY) Unveils $5B Virginia Facility to Ramp Up Bioconjugate and Monoclonal Antibody Production

Insider Monkey

14 days ago

Eli Lilly and Company (LLY) Unveils $5B Virginia Facility to Ramp Up Bioconjugate and Monoclonal Antibody Production

Time to Buy Pfizer (PFE) or Metsera (MTSR) Stock?

Zacks

14 days ago

Time to Buy Pfizer (PFE) or Metsera (MTSR) Stock?

Scholar Rock, A Top 10% Stock, Reverses Higher Despite A Surprise Setback

Investor's Business Daily

14 days ago

Scholar Rock, A Top 10% Stock, Reverses Higher Despite A Surprise Setback

What's Going On With NVIDIA and OpenAI?

Zacks

14 days ago

What's Going On With NVIDIA and OpenAI?

Can PFE Successfully Return to the Obesity Space With Metsera Buyout?

Zacks

15 days ago

Can PFE Successfully Return to the Obesity Space With Metsera Buyout?

Expanding GLP-1 horizons: Novo Nordisk leads MASH therapeutic race

Pharmaceutical Technology

15 days ago

Expanding GLP-1 horizons: Novo Nordisk leads MASH therapeutic race

MT Newswires

15 days ago

European Equities Traded in the US as American Depositary Receipts Rise Tuesday Trading

Can oral GLP-1RAs deliver on the promise of accessible obesity care?

Pharmaceutical Technology

15 days ago

Can oral GLP-1RAs deliver on the promise of accessible obesity care?

MT Newswires

15 days ago

Scholar Rock Faces FDA Setback on SMA Drug Due to Manufacturing Site Issues

US FDA declines to approve Scholar Rock's muscle weakness drug; shares fall

Reuters

15 days ago

US FDA declines to approve Scholar Rock's muscle weakness drug; shares fall

Business Wire

15 days ago

FDA Issues Complete Response Letter (CRL) for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA) Solely Related to Observations Identified at Catalent Indiana LLC Fill-Finish Facility

This Hated Stock Suddenly Looks Like an Obesity Bargain

The Wall Street Journal

15 days ago

This Hated Stock Suddenly Looks Like an Obesity Bargain

Analysis: Innovent's weight-loss drug highlights China challenge for Novo, Lilly

Reuters

15 days ago

Analysis: Innovent's weight-loss drug highlights China challenge for Novo, Lilly

Novo Nordisk (NVO) Stock Sinks As Market Gains: Here's Why

Zacks

15 days ago

Novo Nordisk (NVO) Stock Sinks As Market Gains: Here's Why

Pfizer joining GLP-1 race: How Novo & Eli Lilly compare

Yahoo Finance Video

15 days ago

Pfizer joining GLP-1 race: How Novo & Eli Lilly compare

MT Newswires

15 days ago

Sector Update: Consumer Stocks Decline Late Afternoon

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion

The Wall Street Journal

16 days ago

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion

Pfizer Claws Deeper Into The Obesity Space With $4.9 Billion Metsera Deal

Investor's Business Daily

16 days ago

Pfizer Claws Deeper Into The Obesity Space With $4.9 Billion Metsera Deal

3 Dirt-Cheap Stocks to Buy Right Now

Motley Fool

16 days ago

3 Dirt-Cheap Stocks to Buy Right Now

This Anti-Obesity Stock Jumps 60% on $7.3 Billion Bid by Pfizer

Barrons.com

16 days ago

This Anti-Obesity Stock Jumps 60% on $7.3 Billion Bid by Pfizer

Pfizer seals up to $7.3bn takeover of weight loss drugmaker Metsera

Financial Times

16 days ago

Pfizer seals up to $7.3bn takeover of weight loss drugmaker Metsera

Share on Social Networks: